Page last updated: 2024-08-24

isothiocyanic acid and Androgen-Independent Prostatic Cancer

isothiocyanic acid has been researched along with Androgen-Independent Prostatic Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, F; Hu, DP; Hu, WY; Ou, S; Prins, GS; Qin, Z; Sorensen, K; Xu, L; Yang, Z; Zhang, Y	1

Other Studies

1 other study(ies) available for isothiocyanic acid and Androgen-Independent Prostatic Cancer

Article	Year
Design and synthesis of isothiocyanate-containing hybrid androgen receptor (AR) antagonist to downregulate AR and induce ferroptosis in GSH-Deficient prostate cancer cells. Chemical biology & drug design, 2021, Volume: 97, Issue:5 Topics: Androgen Receptor Antagonists; Binding Sites; Buthionine Sulfoximine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Design; Ferroptosis; Glutathione; Humans; Isothiocyanates; Male; Molecular Docking Simulation; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Receptors, Androgen; Transcriptional Activation	2021

Article

Year

Design and synthesis of isothiocyanate-containing hybrid androgen receptor (AR) antagonist to downregulate AR and induce ferroptosis in GSH-Deficient prostate cancer cells.

Chemical biology & drug design, 2021, Volume: 97, Issue:5

Topics: Androgen Receptor Antagonists; Binding Sites; Buthionine Sulfoximine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Design; Ferroptosis; Glutathione; Humans; Isothiocyanates; Male; Molecular Docking Simulation; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Receptors, Androgen; Transcriptional Activation

2021